Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease

NCT01036139 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
268
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Bioprojet